SCHEMBL4665822

SCHEMBL4665822

CCc1cc(N)n(-c2cnccc2C)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.46
CA1 P00915 4/20 0.46
CA2 P00918 4/20 0.46
CA9 Q16790 4/20 0.46
TGFBR1 P36897 1/20 0.40
MAPT P10636 3/20 0.37
ALDH1A1 P00352 3/20 0.37
PDE9A O76083 2/20 0.35
P2RX7 Q99572 1/20 0.35
NOS3 P29474 1/20 0.33
NOS2 P35228 1/20 0.33
KDM4E B2RXH2 1/20 0.32
NAMPT P43490 1/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C19 P33261 2/20 0.32
CYP2E1 P05181 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C8 P10632 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2A6 P11509 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27836991 0.86 TLR7 (0.44) CA12CA1CA2CA9TGFBR1
SCHEMBL4794858 0.82 CA12 (0.43) CA12CA1CA2CA9TGFBR1
SCHEMBL1010944 0.77 KDM4E (0.40) CA12CA1CA2CA9MAPT
SCHEMBL4667093 0.76 RAB9A (0.43) CA12CA1CA2CA9MAPT
SCHEMBL4665083 0.76 MAPT (0.46) CA12CA1CA2CA9MAPT
SCHEMBL4665662 0.71 NOS3 (0.40) CA12CA1CA2CA9MAPT
SCHEMBL2474225 0.70 RAB9A (0.58) CA1CA2CA9MAPTALDH1A1
SCHEMBL1013253 0.68 CYP1A2 (0.61) MAPTALDH1A1KDM4ECYP1A2CYP2C19
SCHEMBL15210050 0.67 SLC9A1 (0.43) TGFBR1MAPTP2RX7KDM4EMEN1
SCHEMBL4666100 0.67 MAPT (0.47) MAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed